8 results
S-1/A
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
to a minority of patients. It has been hypothesized that treatment results can be significantly improved by optimizing recognition of the specific tumor antigens
S-1
CADL
Candel Therapeutics Inc
25 Jun 21
IPO registration
5:28pm
accrues only to a minority of patients. It has been hypothesized that treatment results can be significantly improved by optimizing recognition
DRS/A
a3szy35c sodqablvq
31 Mar 21
Draft registration statement (amended)
12:00am
10-K
iy5w3189araqjwci0n9
29 Mar 22
Annual report
8:46am
424B4
97b63pxhke2 skt
28 Jul 21
Prospectus supplement with pricing info
4:02pm
- Prev
- 1
- Next